APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bevacizumab Generics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bevacizumab Generics Industry Growth and Trends Forecast to 2032

27 December 2025106 pages

Choose your research edition.

Industry ResearchBevacizumab Generics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Bevacizumab Generics Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Bevacizumab Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bevacizumab Generics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bevacizumab Generics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Bevacizumab Generics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bevacizumab Generics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bevacizumab Generics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bevacizumab Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bevacizumab Generics include Amgen, Amneal Pharmaceuticals, Celltrion Healthcare, Pfizer, Bio-Thera Solutions, Zhejiang Beta Pharma, Jiangsu Hengrui Pharmaceuticals, Qilu Pharma and Shanghai Henlius Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bevacizumab Generics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bevacizumab Generics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bevacizumab Generics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bevacizumab Generics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bevacizumab Generics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bevacizumab Generics Market by Company

Amgen

Amneal Pharmaceuticals

Celltrion Healthcare

Pfizer

Bio-Thera Solutions

Zhejiang Beta Pharma

Jiangsu Hengrui Pharmaceuticals

Qilu Pharma

Shanghai Henlius Biotech

SinoCellTech

Innovent

Chia Tai Tianqing

Bevacizumab Generics Segment by Type

100mg per Vial

400mg per Vial

Bevacizumab Generics Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Bevacizumab Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bevacizumab Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bevacizumab Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bevacizumab Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bevacizumab Generics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bevacizumab Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg per Vial Table 2. Major Company of 400mg per Vial Table 3. Global Bevacizumab Generics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bevacizumab Generics Sales by Type (2021-2026) & (K Units) Table 5. Global Bevacizumab Generics Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bevacizumab Generics Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bevacizumab Generics Sales Market Share in Value by Type (2021-2026) Table 8. Global Bevacizumab Generics Price by Type (2021-2026) & (US$/Unit) Table 9. Global Bevacizumab Generics Sales by Type (2027-2032) & (K Units) Table 10. Global Bevacizumab Generics Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bevacizumab Generics Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bevacizumab Generics Sales Market Share in Value by Type (2027-2032) Table 13. Global Bevacizumab Generics Price by Type (2027-2032) & (US$/Unit) Table 14. North America Bevacizumab Generics Sales by Type (2021-2026) & (K Units) Table 15. North America Bevacizumab Generics Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bevacizumab Generics Sales by Type (2021-2026) & (K Units) Table 17. Europe Bevacizumab Generics Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bevacizumab Generics Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Bevacizumab Generics Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bevacizumab Generics Sales by Type (2021-2026) & (K Units) Table 21. Latin America Bevacizumab Generics Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bevacizumab Generics Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Bevacizumab Generics Sales by Type (2021-2026) & (US$ Million) Table 24. Bevacizumab Generics Industry Trends Table 25. Bevacizumab Generics Industry Drivers Table 26. Bevacizumab Generics Industry Opportunities and Challenges Table 27. Bevacizumab Generics Industry Restraints Table 28. Global Bevacizumab Generics Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bevacizumab Generics Revenue Market Share by Company (2021-2026) Table 30. Global Bevacizumab Generics Sales by Company (2021-2026) & (K Units) Table 31. Global Bevacizumab Generics Sales Share by Company (2021-2026) Table 32. Global Bevacizumab Generics Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Bevacizumab Generics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bevacizumab Generics Major Company Production Sites and Headquarters Table 35. Global Bevacizumab Generics Company, Product Type & Application Table 36. Global Bevacizumab Generics Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bevacizumab Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bevacizumab Generics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bevacizumab Generics Sales by Region (2021-2026) & (K Units) Table 41. Global Bevacizumab Generics Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bevacizumab Generics Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bevacizumab Generics Sales Market Share in Value by Region (2021-2026) Table 44. Global Bevacizumab Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Bevacizumab Generics Sales by Region (2027-2032) & (K Units) Table 46. Global Bevacizumab Generics Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bevacizumab Generics Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bevacizumab Generics Sales Market Share in Value by Region (2027-2032) Table 49. Global Bevacizumab Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Bevacizumab Generics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bevacizumab Generics Sales by Application (2021-2026) & (K Units) Table 52. Global Bevacizumab Generics Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bevacizumab Generics Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bevacizumab Generics Sales Market Share in Value by Application (2021-2026) Table 55. Global Bevacizumab Generics Price by Application (2021-2026) & (US$/Unit) Table 56. Global Bevacizumab Generics Sales by Application (2027-2032) & (K Units) Table 57. Global Bevacizumab Generics Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bevacizumab Generics Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bevacizumab Generics Sales Market Share in Value by Application (2027-2032) Table 60. Global Bevacizumab Generics Price by Application (2027-2032) & (US$/Unit) Table 61. North America Bevacizumab Generics Sales by Application (2021-2026) & (K Units) Table 62. North America Bevacizumab Generics Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bevacizumab Generics Sales by Application (2021-2026) & (K Units) Table 64. Europe Bevacizumab Generics Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bevacizumab Generics Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Bevacizumab Generics Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bevacizumab Generics Sales by Application (2021-2026) & (K Units) Table 68. Latin America Bevacizumab Generics Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bevacizumab Generics Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Bevacizumab Generics Sales by Application (2021-2026) & (US$ Million) Table 71. Amgen Company Information Table 72. Amgen Business Overview Table 73. Amgen Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Amgen Bevacizumab Generics Product Portfolio Table 75. Amgen Recent Development Table 76. Amneal Pharmaceuticals Company Information Table 77. Amneal Pharmaceuticals Business Overview Table 78. Amneal Pharmaceuticals Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Amneal Pharmaceuticals Bevacizumab Generics Product Portfolio Table 80. Amneal Pharmaceuticals Recent Development Table 81. Celltrion Healthcare Company Information Table 82. Celltrion Healthcare Business Overview Table 83. Celltrion Healthcare Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Celltrion Healthcare Bevacizumab Generics Product Portfolio Table 85. Celltrion Healthcare Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pfizer Bevacizumab Generics Product Portfolio Table 90. Pfizer Recent Development Table 91. Bio-Thera Solutions Company Information Table 92. Bio-Thera Solutions Business Overview Table 93. Bio-Thera Solutions Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Bio-Thera Solutions Bevacizumab Generics Product Portfolio Table 95. Bio-Thera Solutions Recent Development Table 96. Zhejiang Beta Pharma Company Information Table 97. Zhejiang Beta Pharma Business Overview Table 98. Zhejiang Beta Pharma Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Zhejiang Beta Pharma Bevacizumab Generics Product Portfolio Table 100. Zhejiang Beta Pharma Recent Development Table 101. Jiangsu Hengrui Pharmaceuticals Company Information Table 102. Jiangsu Hengrui Pharmaceuticals Business Overview Table 103. Jiangsu Hengrui Pharmaceuticals Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Jiangsu Hengrui Pharmaceuticals Bevacizumab Generics Product Portfolio Table 105. Jiangsu Hengrui Pharmaceuticals Recent Development Table 106. Qilu Pharma Company Information Table 107. Qilu Pharma Business Overview Table 108. Qilu Pharma Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Qilu Pharma Bevacizumab Generics Product Portfolio Table 110. Qilu Pharma Recent Development Table 111. Shanghai Henlius Biotech Company Information Table 112. Shanghai Henlius Biotech Business Overview Table 113. Shanghai Henlius Biotech Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shanghai Henlius Biotech Bevacizumab Generics Product Portfolio Table 115. Shanghai Henlius Biotech Recent Development Table 116. SinoCellTech Company Information Table 117. SinoCellTech Business Overview Table 118. SinoCellTech Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. SinoCellTech Bevacizumab Generics Product Portfolio Table 120. SinoCellTech Recent Development Table 121. Innovent Company Information Table 122. Innovent Business Overview Table 123. Innovent Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Innovent Bevacizumab Generics Product Portfolio Table 125. Innovent Recent Development Table 126. Chia Tai Tianqing Company Information Table 127. Chia Tai Tianqing Business Overview Table 128. Chia Tai Tianqing Bevacizumab Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Chia Tai Tianqing Bevacizumab Generics Product Portfolio Table 130. Chia Tai Tianqing Recent Development Table 131. North America Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Bevacizumab Generics Sales by Country (2021-2026) & (K Units) Table 133. North America Bevacizumab Generics Sales Market Share by Country (2021-2026) Table 134. North America Bevacizumab Generics Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Bevacizumab Generics Sales Market Share Forecast by Country (2027-2032) Table 136. North America Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Bevacizumab Generics Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Bevacizumab Generics Market Share by Country (2021-2026) Table 139. North America Bevacizumab Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Bevacizumab Generics Market Share Forecast by Country (2027-2032) Table 141. Europe Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Bevacizumab Generics Sales by Country (2021-2026) & (K Units) Table 143. Europe Bevacizumab Generics Sales Market Share by Country (2021-2026) Table 144. Europe Bevacizumab Generics Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Bevacizumab Generics Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Bevacizumab Generics Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Bevacizumab Generics Market Share by Country (2021-2026) Table 149. Europe Bevacizumab Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Bevacizumab Generics Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Bevacizumab Generics Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Bevacizumab Generics Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Bevacizumab Generics Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Bevacizumab Generics Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Bevacizumab Generics Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Bevacizumab Generics Market Share by Country (2021-2026) Table 159. Asia-Pacific Bevacizumab Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Bevacizumab Generics Market Share Forecast by Country (2027-2032) Table 161. Latin America Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Bevacizumab Generics Sales by Country (2021-2026) & (K Units) Table 163. Latin America Bevacizumab Generics Sales Market Share by Country (2021-2026) Table 164. Latin America Bevacizumab Generics Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Bevacizumab Generics Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Bevacizumab Generics Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Bevacizumab Generics Market Share by Country (2021-2026) Table 169. Latin America Bevacizumab Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Bevacizumab Generics Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Bevacizumab Generics Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Bevacizumab Generics Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Bevacizumab Generics Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Bevacizumab Generics Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Bevacizumab Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Bevacizumab Generics Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Bevacizumab Generics Market Share by Country (2021-2026) Table 179. Middle East and Africa Bevacizumab Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Bevacizumab Generics Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Bevacizumab Generics Distributors List Table 184. Bevacizumab Generics Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Bevacizumab Generics Image Figure 2. Global Bevacizumab Generics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bevacizumab Generics Market Size (2021-2032) & (US$ Million) Figure 4. Global Bevacizumab Generics Sales (2021-2032) & (K Units) Figure 5. 100mg per Vial Image Figure 6. Global 100mg per Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 400mg per Vial Image Figure 8. Global 400mg per Vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Bevacizumab Generics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bevacizumab Generics Market Share by Type 2025 VS 2032 Figure 11. North America Bevacizumab Generics Sales Market Share in Volume by Type in 2025 Figure 12. North America Bevacizumab Generics Sales Market Share in Value by Type in 2025 Figure 13. Europe Bevacizumab Generics Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bevacizumab Generics Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bevacizumab Generics Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bevacizumab Generics Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bevacizumab Generics Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bevacizumab Generics Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bevacizumab Generics Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bevacizumab Generics Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bevacizumab Generics Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Bevacizumab Generics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Bevacizumab Generics Market Share by Application 2025 VS 2032 Figure 31. North America Bevacizumab Generics Sales Market Share in Volume by Application in 2025 Figure 32. North America Bevacizumab Generics Sales Market Share in Value by Application in 2025 Figure 33. Europe Bevacizumab Generics Sales Market Share in Volume by Application in 2025 Figure 34. Europe Bevacizumab Generics Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Bevacizumab Generics Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Bevacizumab Generics Sales Market Share in Value by Application in 2025 Figure 37. Latin America Bevacizumab Generics Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Bevacizumab Generics Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Bevacizumab Generics Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Bevacizumab Generics Sales Market Share in Value by Application in 2025 Figure 41. North America Bevacizumab Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Bevacizumab Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Bevacizumab Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Bevacizumab Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Bevacizumab Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Bevacizumab Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bevacizumab Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Bevacizumab Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Bevacizumab Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Bevacizumab Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bevacizumab Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Bevacizumab Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Bevacizumab Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Bevacizumab Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bevacizumab Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Bevacizumab Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Bevacizumab Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Bevacizumab Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bevacizumab Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Bevacizumab Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Bevacizumab Generics Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Bevacizumab Generics Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Vial
  • 400mg per Vial
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Amgen
  • Amneal Pharmaceuticals
  • Celltrion Healthcare
  • Pfizer
  • Bio-Thera Solutions
  • Zhejiang Beta Pharma
  • Jiangsu Hengrui Pharmaceuticals
  • Qilu Pharma
  • Shanghai Henlius Biotech
  • SinoCellTech
  • Innovent
  • Chia Tai Tianqing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bevacizumab Generics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bevacizumab Generics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bevacizumab Generics Market by Type
  6. 1.3.1 100mg per Vial
  7. 1.3.2 400mg per Vial
  8. 1.4 Global Bevacizumab Generics Market Size by Type
  9. 1.4.1 Global Bevacizumab Generics Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bevacizumab Generics Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bevacizumab Generics Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bevacizumab Generics Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bevacizumab Generics Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bevacizumab Generics Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bevacizumab Generics Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bevacizumab Generics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bevacizumab Generics Industry Trends
  2. 2.2 Bevacizumab Generics Industry Drivers
  3. 2.3 Bevacizumab Generics Industry Opportunities and Challenges
  4. 2.4 Bevacizumab Generics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bevacizumab Generics Revenue (2021-2026)
  2. 3.2 Global Top Players by Bevacizumab Generics Sales (2021-2026)
  3. 3.3 Global Top Players by Bevacizumab Generics Price (2021-2026)
  4. 3.4 Global Bevacizumab Generics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bevacizumab Generics Major Company Production Sites & Headquarters
  6. 3.6 Global Bevacizumab Generics Company, Product Type & Application
  7. 3.7 Global Bevacizumab Generics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bevacizumab Generics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bevacizumab Generics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bevacizumab Generics Tier 1, Tier 2, and Tier 3
4 Bevacizumab Generics Regional Status and Outlook
  1. 4.1 Global Bevacizumab Generics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bevacizumab Generics Historic Market Size by Region
  3. 4.2.1 Global Bevacizumab Generics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bevacizumab Generics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bevacizumab Generics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bevacizumab Generics Forecasted Market Size by Region
  7. 4.3.1 Global Bevacizumab Generics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bevacizumab Generics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bevacizumab Generics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bevacizumab Generics by Application
  1. 5.1 Bevacizumab Generics Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Bevacizumab Generics Market Size by Application
  6. 5.2.1 Global Bevacizumab Generics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bevacizumab Generics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bevacizumab Generics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bevacizumab Generics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bevacizumab Generics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bevacizumab Generics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bevacizumab Generics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bevacizumab Generics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amgen
  2. 6.1.1 Amgen Company Information
  3. 6.1.2 Amgen Business Overview
  4. 6.1.3 Amgen Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amgen Bevacizumab Generics Product Portfolio
  6. 6.1.5 Amgen Recent Developments
  7. 6.2 Amneal Pharmaceuticals
  8. 6.2.1 Amneal Pharmaceuticals Company Information
  9. 6.2.2 Amneal Pharmaceuticals Business Overview
  10. 6.2.3 Amneal Pharmaceuticals Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amneal Pharmaceuticals Bevacizumab Generics Product Portfolio
  12. 6.2.5 Amneal Pharmaceuticals Recent Developments
  13. 6.3 Celltrion Healthcare
  14. 6.3.1 Celltrion Healthcare Company Information
  15. 6.3.2 Celltrion Healthcare Business Overview
  16. 6.3.3 Celltrion Healthcare Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Celltrion Healthcare Bevacizumab Generics Product Portfolio
  18. 6.3.5 Celltrion Healthcare Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Bevacizumab Generics Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Bio-Thera Solutions
  26. 6.5.1 Bio-Thera Solutions Company Information
  27. 6.5.2 Bio-Thera Solutions Business Overview
  28. 6.5.3 Bio-Thera Solutions Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bio-Thera Solutions Bevacizumab Generics Product Portfolio
  30. 6.5.5 Bio-Thera Solutions Recent Developments
  31. 6.6 Zhejiang Beta Pharma
  32. 6.6.1 Zhejiang Beta Pharma Company Information
  33. 6.6.2 Zhejiang Beta Pharma Business Overview
  34. 6.6.3 Zhejiang Beta Pharma Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zhejiang Beta Pharma Bevacizumab Generics Product Portfolio
  36. 6.6.5 Zhejiang Beta Pharma Recent Developments
  37. 6.7 Jiangsu Hengrui Pharmaceuticals
  38. 6.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
  39. 6.7.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  40. 6.7.3 Jiangsu Hengrui Pharmaceuticals Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jiangsu Hengrui Pharmaceuticals Bevacizumab Generics Product Portfolio
  42. 6.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  43. 6.8 Qilu Pharma
  44. 6.8.1 Qilu Pharma Company Information
  45. 6.8.2 Qilu Pharma Business Overview
  46. 6.8.3 Qilu Pharma Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Qilu Pharma Bevacizumab Generics Product Portfolio
  48. 6.8.5 Qilu Pharma Recent Developments
  49. 6.9 Shanghai Henlius Biotech
  50. 6.9.1 Shanghai Henlius Biotech Company Information
  51. 6.9.2 Shanghai Henlius Biotech Business Overview
  52. 6.9.3 Shanghai Henlius Biotech Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shanghai Henlius Biotech Bevacizumab Generics Product Portfolio
  54. 6.9.5 Shanghai Henlius Biotech Recent Developments
  55. 6.10 SinoCellTech
  56. 6.10.1 SinoCellTech Company Information
  57. 6.10.2 SinoCellTech Business Overview
  58. 6.10.3 SinoCellTech Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 SinoCellTech Bevacizumab Generics Product Portfolio
  60. 6.10.5 SinoCellTech Recent Developments
  61. 6.11 Innovent
  62. 6.11.1 Innovent Company Information
  63. 6.11.2 Innovent Business Overview
  64. 6.11.3 Innovent Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Innovent Bevacizumab Generics Product Portfolio
  66. 6.11.5 Innovent Recent Developments
  67. 6.12 Chia Tai Tianqing
  68. 6.12.1 Chia Tai Tianqing Company Information
  69. 6.12.2 Chia Tai Tianqing Business Overview
  70. 6.12.3 Chia Tai Tianqing Bevacizumab Generics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chia Tai Tianqing Bevacizumab Generics Product Portfolio
  72. 6.12.5 Chia Tai Tianqing Recent Developments
7 North America by Country
  1. 7.1 North America Bevacizumab Generics Sales by Country
  2. 7.1.1 North America Bevacizumab Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bevacizumab Generics Sales by Country (2021-2026)
  4. 7.1.3 North America Bevacizumab Generics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bevacizumab Generics Market Size by Country
  6. 7.2.1 North America Bevacizumab Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bevacizumab Generics Market Size by Country (2021-2026)
  8. 7.2.3 North America Bevacizumab Generics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bevacizumab Generics Sales by Country
  2. 8.1.1 Europe Bevacizumab Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bevacizumab Generics Sales by Country (2021-2026)
  4. 8.1.3 Europe Bevacizumab Generics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bevacizumab Generics Market Size by Country
  6. 8.2.1 Europe Bevacizumab Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bevacizumab Generics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bevacizumab Generics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bevacizumab Generics Sales by Country
  2. 9.1.1 Asia-Pacific Bevacizumab Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bevacizumab Generics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bevacizumab Generics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bevacizumab Generics Market Size by Country
  6. 9.2.1 Asia-Pacific Bevacizumab Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bevacizumab Generics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bevacizumab Generics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bevacizumab Generics Sales by Country
  2. 10.1.1 South America Bevacizumab Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bevacizumab Generics Sales by Country (2021-2026)
  4. 10.1.3 South America Bevacizumab Generics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bevacizumab Generics Market Size by Country
  6. 10.2.1 South America Bevacizumab Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bevacizumab Generics Market Size by Country (2021-2026)
  8. 10.2.3 South America Bevacizumab Generics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bevacizumab Generics Sales by Country
  2. 11.1.1 Middle East and Africa Bevacizumab Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bevacizumab Generics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bevacizumab Generics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bevacizumab Generics Market Size by Country
  6. 11.2.1 Middle East and Africa Bevacizumab Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bevacizumab Generics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bevacizumab Generics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bevacizumab Generics Value Chain Analysis
  2. 12.1.1 Bevacizumab Generics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bevacizumab Generics Production Mode & Process
  7. 12.2 Bevacizumab Generics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bevacizumab Generics Distributors
  10. 12.2.3 Bevacizumab Generics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst